ANDHealth – prepared contracts to establish a consortium to implement an integrated ecosystem for the development and commercialisation of evidence-based digital health products. Solubility incorporated the company, assisted in negotiating the founding funding agreement with MTPConnect, and drafted the consortium agreement amongst the founding members, Novartis, Murdoch Childrens Research Institute, RMIT, AusBiotech, Health XL, Curve Tomorrow, Planet Innovation and GP2U.
CSL (ASX:CSL) and Seqirus – act as ongoing lead external counsel in long term tender contracts with the Australian Government for supply of certain essential pharmaceutical products, total value $400m-$1bn.
Cynata Therapeutics Ltd (ASX: CYP) – acted on development and commercialisation partnership agreement with Fujifilm Corporation, under which Fujifilm took an equity stake of $4m, and agreed to double digit royalties on sales and potential future upfront and milestone payments to Cynata in excess of $60m.
Premneo Pharmaceuticals – acted for this new company established by Dr Brian McNamee (former CSL CEO) on drafting and negotiating in-licence agreement and related contracts for Premneo to license from Clover Corporation Limited a patent family owned by Clover and three patent families in-licensed by Clover from each of Cornell University, CSIRO and Women’s and Children’s Research Institute (Adelaide).
Spinifex Pharmaceuticals– acted as local lead counsel in its US$40m Series C financing and re-domestication and also in its subsequent sale to Novartis International AG, for an upfront cash consideration of US$200 million plus undisclosed clinical development and regulatory milestone payments.
St Vincent’s Institute – acted on its collaborative partnership with Janssen Pharmaceuticals, Inc aimed at developing and commercialising small molecule modulators of microgial function and inflammation for reducing amyloid plaque burden and Alzheimer’s disease severity.
Australian Tapestry Foundation – tapestry commissioning
Bellroy – trade mark portfolio management
Blamey & Saunders Hearing – investment and general commercial
Cartherics – research collaboration agreements
Cognition Therapeutics – intercompany agreements for R&D tax incentive, and local Australian counsel
Hatchtech – investment and general commercial and local Australian counsel on exit
Innavac – licensing and general commercial
Lenswood Cold Stores Co-operative Society and Next Fruit Generation Australia – trade mark portfolio management
Livac – general commercial and pro-forma drafting
Melbourne Business School – investment and training material preparation
National Serology Reference Laboratory – supply and distribution of reagents
Oculo – structuring, investment, general commercial, general commercial and pro-forma drafting and trade mark portfolio management
OPAL Rheumatology – structuring, general commercial and pro-forma drafting
Patrys (ASX: PAB) – investment, business acquisition and general commercial
Petri Exchange – structuring, general commercial, AFSL advice and pro-forma drafting
The University of Melbourne – spin-off and start-up licensing, general commercial and pro-forma drafting
Verva Pharmaceuticals – business divestment